How nerve signals influence bone cells
A novel cell-autonomous role for β-adrenergic receptor signaling in osteoclasts
This project looks at how nerve signals affect bone-resorbing cells, especially in older adults and post-menopausal women, to better understand bone loss.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mainehealth NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-11092002 on NIH RePORTER |
What this research studies
The sympathetic nervous system, which controls our 'fight or flight' response, also plays a role in bone health and can contribute to bone loss as we age. In post-menopausal women, increased activity in this system can lead to less bone being built and more bone being broken down. This project focuses on how certain nerve signals, specifically through beta-adrenergic receptors, directly affect bone-resorbing cells called osteoclasts. Researchers are exploring how common medications like beta-blockers, which block these signals, might protect bones by reducing bone breakdown. The goal is to uncover new ways to prevent or treat bone loss by targeting these specific pathways within bone cells.
Who could benefit from this research
Good fit: This foundational research is most relevant to patients experiencing age-related bone loss or osteoporosis, especially post-menopausal women, who might benefit from future treatments targeting nerve-bone interactions.
Not a fit: Patients without bone loss conditions or those whose bone health issues are unrelated to sympathetic nervous system activity may not directly benefit from this specific line of research.
Why it matters
Potential benefit: If successful, this work could lead to new strategies or repurpose existing medications like beta-blockers to prevent or treat bone loss, particularly in conditions like osteoporosis.
How similar studies have performed: Large population studies and preliminary lab data suggest that beta-blockers are associated with better bone health, but this project aims to uncover the specific cellular mechanisms behind these observations.
Where this research is happening
Portland, United States
- Mainehealth — Portland, United States (Active)
Researchers
- Principal investigator: Motyl, Katherine Jean — Mainehealth
- Study coordinator: Motyl, Katherine Jean
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.